Optimal Management of HIV Infected Adults at Risk for Kidney Disease in Nigeria
Principal Investigator(s): Muktar Aliyu, M.D., M.P.H., Dr.P.H.William Wester, M.D., M.P.H.
Etiology of Persistent Microalbuminuria in Nigeria
The Vanderbilt Institute for Global Health (VIGH) and Aminu Kano Teaching Hospital (AKTH) in Kano, Nigeria have received a federal grant to study the factors associated with microalbuminuria among participants in an ongoing clinical trial of genetically at-risk HIV-positive adult Nigerians. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant will provide $2.2 million over the next four years.
Vanderbilt-Nigeria Building Research Capacity in HIV/Non-communicable Diseases (V-BRCH)
The Vanderbilt-Nigeria Building Research Capacity in HIV/Non-communicable Diseases (V-BRCH) Program builds capacity of Nigerian investigators to successfully initiate and implement high-quality clinical trials in HIV-associated non-communicable diseases.
Avante: Towards Epidemic Control
Principal Investigator(s):William Wester, M.D., M.P.H.